Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-5890

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figr1 (Figr1)

A pharmacokinetic fold change chart showing interactions between Venlafaxine Hydrochloride and various drugs (Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, Lithium). The chart plots changes in Cmax and AUC of venlafaxine and its metabolite ODV, with recommendations such as avoiding concomitant use with ethanol and using caution with cimetidine and ketoconazole. The x-axis represents change relative to the reference value.*

FDA Label Image

Figr2 (Figr2)

A horizontal scatter plot chart showing pharmacokinetic fold changes and 90% confidence intervals for various interacting drugs when co-administered with Venlafaxine Hydrochloride. The x-axis represents change relative to a reference value ranging from 0 to 3. The chart includes analytes like ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium with corresponding recommendations such as 'No dose adjustment,' 'Avoid concomitant use,' and 'Clinical significance unknown.'*

FDA Label Image

Figr3 (Figr3)

A scatterplot chart showing pharmacokinetic fold changes and 90% confidence intervals of venlafaxine in special populations. The x-axis represents change relative to a reference value, while the y-axis lists populations such as hepatic impairment of varying severity, renal hemodialysis, CYP2D6 polymorphism, age over 60, and gender. The chart includes analyte measurements like venlafaxine and ODV with PK parameters Cmax and AUC, along with dosing recommendations based on these changes.*

FDA Label Image

Label Image (Lbl500905890)

Venlafaxine Hydrochloride 150 mg extended-release capsules packaging label from A-S Medication Solutions. The label includes dose information, storage instructions to keep at 68 to 77 degrees Fahrenheit, and package count of 30 capsules. The NDC number 50090-5890-0 is visible along with barcode and packaging origin details.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Chemical structure of Venlafaxine Hydrochloride, showing molecular components including a chiral center, a methoxy-substituted aromatic ring, and a hydrochloride group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.